CNS Therapeutics
CNS Therapeutics is a private company based in St. Paul, Minn. CNS Therapeutics develops and markets safe, high-quality pharmaceuticals for site-specific delivery to the central nervous system to treat neurological disorders and chronic pain. In addition to its first FDA-approved product, Gablofen, CNS Therapeutics is currently collaborating with U.S. and international scientific experts to develop and test new treatments for pain and Parkinson’s disease.
Recent Milestones
Videos
Screenshots
Above: CNS Therapeutics
Uploaded: 9/25/12
Sources
-
Covidien unit to acquire CNS Therapeutics for approximately $100M (finance.yahoo.com) [edit]
